NIAID, part of the National Institutes of Health, will contribute about $29 million annually for the next seven years to fund the effort.
Researchers will identify various vaccine, diagnostic and therapeutic candidates to conduct clinical trials at nine institutions across the U.S. The research consortium will also be equipped to quickly implement targeted trials in response to public health emergencies.
To learn more about the initiative, click here.
More articles on clinical leadership & infection control:
8 clinical leaders share tips for improving the patient experience
University Hospitals employee gives patient kidney
‘Hospital of horrors’: Children abused, improperly medicated at Chicago facility, lawsuit says
